September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Optimizing a Biodegradable Scaffold for Clinical Applications of iPS Cell Derived RPE Tissue
Author Affiliations & Notes
  • Vladimir Khristov
    National Eye Institute, Bethesda, Maryland, United States
  • Nathan Hotaling
    National Eye Institute, Bethesda, Maryland, United States
  • Yichao Li
    National Eye Institute, Bethesda, Maryland, United States
  • Haohua Qian
    National Eye Institute, Bethesda, Maryland, United States
  • Qin Wan
    National Eye Institute, Bethesda, Maryland, United States
  • Ruchi Sharma
    National Eye Institute, Bethesda, Maryland, United States
  • Arvydas Maminishkis
    National Eye Institute, Bethesda, Maryland, United States
  • Juan Amaral
    National Eye Institute, Bethesda, Maryland, United States
  • Sheldon S Miller
    National Eye Institute, Bethesda, Maryland, United States
  • Janine Davis
    National Eye Institute, Bethesda, Maryland, United States
  • Kapil Bharti
    National Eye Institute, Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Vladimir Khristov, None; Nathan Hotaling, None; Yichao Li, None; Haohua Qian, None; Qin Wan, None; Ruchi Sharma, None; Arvydas Maminishkis, None; Juan Amaral, None; Sheldon Miller, None; Janine Davis, None; Kapil Bharti, None
  • Footnotes
    Support  NIH/NEI, NIH/NIA Intramural Research Program and Common Fund Therapeutic Challenge Award
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3739. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vladimir Khristov, Nathan Hotaling, Yichao Li, Haohua Qian, Qin Wan, Ruchi Sharma, Arvydas Maminishkis, Juan Amaral, Sheldon S Miller, Janine Davis, Kapil Bharti; Optimizing a Biodegradable Scaffold for Clinical Applications of iPS Cell Derived RPE Tissue. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3739.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Previous work suggests replacing diseased RPE with a healthy autologous RPE sheet can provide vision rescue for AMD patients. Here we evaluate biodegradable and non-biodegradable substrates for RPE sheet maturation, biocompatibility, and degradation in vivo and in vitro.

Methods : Induced pluripotent stem (iPS) cells are differentiated into RPE using a directed-differentiation protocol with three phases: neuroectoderm/RPE progenitor, committed and immature RPE. Immature RPE cells are seeded onto electrospun poly(lactic-co-glycolic acid) (PLGA) or non-biodegradable polyester scaffolds. RPE on these two scaffolds are evaluated in vitro using molecular and electrophysiological assays and in vivo for biodegradability, mechanical properties, and biocompatibility. Mature tissues are implanted in a laser-injured pig eye subretinal space and evaluated using optical coherence tomography, multifocal ERG, and histology.

Results : PLGA and polyester substrates produce functionally similar tissues in vitro. Electrophysiological and gene expression experiments show that RPE cells grown on PLGA scaffolds and polyester membranes form single cell layer, develop transepithelial resistance more than 200 ohms/cm2, and show electrophysiological responses to [K+] and ATP changes that are similar to responses previously observed in native human RPE. In vitro evaluation of PLGA scaffolds showed complete degradation over 8-10 weeks, without affecting RPE monolayer integrity. Following transplantation into pig subretinal space, PLGA scaffold continued to degrade without causing toxicity to the RPE monolayer. RPE monolayer on biodegradable scaffold rescued laser-induced RPE and retina injury. These PLGA scaffolds showed comparable integration results to polyester implants.

Conclusions : We confirm that biodegradable substrates are suitable for RPE transplantation in degenerative eye diseases. RPE cells behave similar on biodegradable and non-biodegradable substrates, forming a tissue similar to native RPE in its molecular and functional properties. Biodegradability and biocompatibility data from a pig model demonstrates that PLGA scaffold is safe, with the added benefit of being resorbed by the surrounding tissue over time, leaving no foreign material in the eye.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×